Carnitines slow down tumor development of colon cancer in the DMH-chemical carcinogenesis mouse model

Journal of Cellular Biochemistry

Volumn 114, Issue 7, 2013, Pages 1665-1673

  Roscilli, Giuseppe ^a   Marra, Emanuele ^a   Mori, Federica ^a   Di Napoli, Arianna ^b   Mancini, Rita ^b,g   Serlupi Crescenzi, Ottaviano ^c   Virmani, Ashraf ^c   Aurisicchio, Luigi ^a,d   Ciliberto, Gennaro ^e,f  

^a Takis srl   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c Sigma Tau SpA   (Italy)

^d Grande Ospedale Metropolitano   (Italy)

^e UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^f NATIONAL CANCER INSTITUTE   (Italy)

^g SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

ANIMAL MODEL; APOPTOSIS; CARNITINE; COLON CANCER; CURCUMIN; GROWTH ARREST

Indexed keywords

1,2 DIMETHYLHYDRAZINE; ACYLCARNITINE; BETA CATENIN; CURCUMIN; LEVACECARNINE; PROPIONYLCARNITINE;

ADVANCED CANCER; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER PREVENTION; CANCER STAGING; CELL PROLIFERATION; CELL VIABILITY; COLON ADENOMA; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG SCREENING; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; METASTASIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TREATMENT DURATION;

1,2-DIMETHYLHYDRAZINE; ACETYLCARNITINE; ANIMALS; APOPTOSIS; CARNITINE; CELL PROLIFERATION; COLONIC NEOPLASMS; CURCUMIN; HT29 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED BALB C;

EID: 84877718308     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24508     Document Type: Article

References (31)

1. 1998. United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) guidelines for the welfare of animals in experimental neoplasia (second edition). Br J Cancer 77: 1-10.
2. Bieber LL,. 1988. Carnitine. Annu Rev Biochem 57: 261-283.
3. Bremer J,. 1983. Carnitine-Metabolism and functions. Physiol Rev 63: 1420-1480.
4. Calabrese V, Giuffrida Stella AM, Calvani M, Butterfield DA,. 2006. Acetylcarnitine and cellular stress response: Roles in nutritional redox homeostasis and regulation of longevity genes. J Nutr Biochem 17: 73-88. (Pubitemid 43082141)
5. Chen A, Xu J,. 2005. Activation of PPAR{gamma} by curcumin inhibits Moser cell growth and mediates suppression of gene expression of cyclin D1 and EGFR. Am J Physiol Gastrointest Liver Physiol 288: 447-456.
6. Corpet DE, Tache S,. 2002. Most effective colon cancer chemopreventive agents in rats: A systematic review of aberrant crypt foci and tumor data, ranked by potency. Nutr Cancer 43: 1-21. (Pubitemid 35387251)
7. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM,. 2010. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917.
8. Fiala S, Fiala AE, Keller RW, Fiala ES,. 1977. Gamma glutamyl transpeptidase in colon cancer induced by 1,2-dimethylhydrazine. Arch Geschwulstforsch 47: 117-122. (Pubitemid 8123397)
9. Hatcher H, Planalp R, Cho J, Torti FM, Torti SV,. 2008. Curcumin: From ancient medicine to current clinical trials. Cell Mol Life Sci 65: 1631-1652.
10. Huang MT, Lou YR, Ma W, Newmark HL, Reuhl KR, Conney AH,. 1994. Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice. Cancer Res 54: 5841-5847. (Pubitemid 24375217)
11. Ito A, Lai CH, Zhao X, Saito S, Hamilton MH, Appella E, Yao TP,. 2001. p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2. EMBO J 20: 1331-1340. (Pubitemid 32233973)
12. Izgut-Uysal VN, Bulbul M, Tan R, Derin N, Ustunel I, Agar A, Yargicoglu P,. 2007. Effect of chronic stress and L -carnitine on rat stomach. J Physiol Sci 57: 187-192. (Pubitemid 46983417)
13. Kakarala M, Brenner DE, Korkaya H, Cheng C, Tazi K, Ginestier C, Liu S, Dontu G, Wicha MS,. 2010. Targeting breast stem cells with the cancer preventive compounds curcumin and piperine. Breast Cancer Res Treat 122: 777-785.
14. Lee SJ, Krauthauser C, Maduskuie V, Fawcett PT, Olson JM, Rajasekaran SA,. 2011. Curcumin-induced HDAC inhibition and attenuation of medulloblastoma growth in vitro and in vivo. BMC Cancer 11: 144.
15. Lin JK,. 2007. Molecular targets of curcumin. Adv Exp Med Biol 595: 227-243.
16. Madiraju P, Pande SV, Prentki M, Madiraju SR,. 2009. Mitochondrial acetylcarnitine provides acetyl groups for nuclear histone acetylation. Epigenetics 4: 399-403.
17. Mehta K, Pantazis P, McQueen T, Aggarwal BB,. 1997. Antiproliferative effect of curcumin (diferuloylmethane) against human breast tumor cell lines. Anticancer Drugs 8: 470-481. (Pubitemid 27310917)
18. Mukhopadhyay A, Bueso-Ramos C, Chatterjee D, Pantazis P, Aggarwal BB,. 2001. Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines. Oncogene 20: 7597-7609. (Pubitemid 33111860)
19. Perkins S, Verschoyle RD, Hill K, Parveen I, Threadgill MD, Sharma RA, Williams ML, Steward WP, Gescher AJ,. 2002. Chemopreventive efficacy and pharmacokinetics of curcumin in the min/+ mouse, a model of familial adenomatous polyposis. Cancer Epidemiol Biomarkers Prev 11: 535-540. (Pubitemid 34615160)
20. Pisano C, Pratesi G, Laccabue D, Zunino F, Lo Giudice P, Bellucci A, Pacifici L, Camerini B, Vesci L, Castorina M, Cicuzza S, Tredici G, Marmiroli P, Nicolini G, Galbiati S, Calvani M, Carminati P, Cavaletti G,. 2003. Paclitaxel and cisplatin-induced neurotoxicity: A protective role of acetyl- L -carnitine. Clin Cancer Res 9: 5756-5767. (Pubitemid 37499500)
21. Pisano C, Vesci L, Milazzo FM, Guglielmi MB, Fodera R, Barbarino M, D'Incalci M, Zucchetti M, Petrangolini G, Tortoreto M, Perego P, Zuco V, Orlandi A, Passeri D, Carminati P, Cavazza C, Zunino F,. 2010. Metabolic approach to the enhancement of antitumor effect of chemotherapy: A key role of acetyl- L -carnitine. Clin Cancer Res 16: 3944-3953.
22. Sarkar FH, Li Y, Wang Z, Kong D,. 2010. The role of nutraceuticals in the regulation of Wnt and Hedgehog signaling in cancer. Cancer Metastasis Rev 29: 383-394.
23. Sharpless NE, Depinho RA,. 2006. The mighty mouse: Genetically engineered mouse models in cancer drug development. Nat Rev Drug Discov 5: 741-754. (Pubitemid 44323701)
24. Steiber A, Kerner J, Hoppel CL,. 2004. Carnitine: A nutritional, biosynthetic, and functional perspective. Mol Aspects Med 25: 455-473. (Pubitemid 39195071)
25. Surh YJ,. 2003. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 3: 768-780.
26. Takahashi M, Nakatsugi S, Sugimura T, Wakabayashi K,. 2000. Frequent mutations of the beta-catenin gene in mouse colon tumors induced by azoxymethane. Carcinogenesis 21: 1117-1120. (Pubitemid 30389335)
27. Tang Y, Zhao W, Chen Y, Zhao Y, Gu W,. 2008. Acetylation is indispensable for p53 activation. Cell 133: 612-626. (Pubitemid 351636297)
28. Watson JL, Hill R, Yaffe PB, Greenshields A, Walsh M, Lee PW, Giacomantonio CA, Hoskin DW,. 2010. Curcumin causes superoxide anion production and p53-independent apoptosis in human colon cancer cells. Cancer Lett 297: 1-8.
29. Wenzel U, Nickel A, Daniel H,. 2005. Increased carnitine-dependent fatty acid uptake into mitochondria of human colon cancer cells induces apoptosis. J Nutr 135: 1510-1514. (Pubitemid 40799619)
30. Wilken R, Veena MS, Wang MB, Srivatsan ES,. 2011. Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Mol Cancer 10: 12.
31. Wogan GN, Hecht SS, Felton JS, Conney AH, Loeb LA,. 2004. Environmental and chemical carcinogenesis. Semin Cancer Biol 14: 473-486. (Pubitemid 39360995)